Breaking News Instant updates and real-time market news.

HSY

Hershey

$121.57 /

+10.05 (+9.01%)

18:55
03/24/20
03/24
18:55
03/24/20
18:55

Hershey upgraded to Buy from Hold at Edward Jones

Edward Jones analyst John Boylan upgraded Hershey to Buy from Hold.

  • 24

    Mar

  • 14

    Sep

HSY Hershey
$121.57 /

+10.05 (+9.01%)

03/18/20 JPMorgan
Hershey price target lowered to $138 from $152 at JPMorgan
03/18/20 Credit Suisse
Hershey upgraded to Outperform from Neutral at Credit Suisse
01/22/20 Jefferies
Hershey initiated with a Hold at Jefferies
01/22/20 Jefferies
Hershey initiated with a Hold at Jefferies

TODAY'S FREE FLY STORIES

Hot Stocks
Kezar Life Sciences expects cash to fund company into 3Q22  07:08
04/09/20
04/09
07:08
04/09/20
07:08
KZR

Kezar Life Sciences

$3.80 /

+0.04 (+1.06%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Kezar Life Sciences on track for IND application for KZR-261 in 1Q21  07:08
04/09/20
04/09
07:08
04/09/20
07:08
KZR

Kezar Life Sciences

$3.80 /

+0.04 (+1.06%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Pfizer identifies early potential coronavirus treatment, WSJ reports » 07:08
04/09/20
04/09
07:08
04/09/20
07:08
PFE

Pfizer

$34.62 /

+1.01 (+3.01%)

Pfizer has identified an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Kezar Life Sciences anticipates delays in milestones for KZR-616 » 07:08
04/09/20
04/09
07:08
04/09/20
07:08
KZR

Kezar Life Sciences

$3.80 /

+0.04 (+1.06%)

Kezar Life Sciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Rexford Industrial acquires industrial property for $15.5M » 07:08
04/09/20
04/09
07:08
04/09/20
07:08
REXR

Rexford Industrial

$40.22 /

+2.11 (+5.54%)

Rexford Industrial Realty…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
LabCorp, Ciox Health to collaborate on COVID-19 patient data registry » 07:07
04/09/20
04/09
07:07
04/09/20
07:07
LH

LabCorp

$141.02 /

+7.15 (+5.34%)

LabCorp and Ciox Health…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Equifax appoints Lindsay Parker as new Chief Marketing Officer » 07:07
04/09/20
04/09
07:07
04/09/20
07:07
EFX

Equifax

$122.62 /

+6.41 (+5.52%)

Equifax has named Lindsay…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Zosano Pharma initiated with a Buy at H.C. Wainwright » 07:07
04/09/20
04/09
07:07
04/09/20
07:07
ZSAN

Zosano Pharma

$0.53 /

+0.011 (+2.11%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Golden Star Resources initiated with a Market Perform at BMO Capital » 07:07
04/09/20
04/09
07:07
04/09/20
07:07
GSS

Golden Star Resources

$2.40 /

-0.08 (-3.23%)

BMO Capital analyst Raj…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Canada Goose to ramp domestic production of personal protective equipment » 07:06
04/09/20
04/09
07:06
04/09/20
07:06
GOOS

Canada Goose

$21.21 /

+0.925 (+4.56%)

Canada Goose announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Calumet Specialty Products provides operational update, lowers CapEx outlook » 07:05
04/09/20
04/09
07:05
04/09/20
07:05
CLMT

Calumet Specialty Products

$1.09 /

+0.065 (+6.37%)

Calumet Specialty…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Arcturus Therapeutics to initiate human trial of COVID-19 vaccine this summer » 07:05
04/09/20
04/09
07:05
04/09/20
07:05
ARCT

Arcturus Therapeutics

$13.83 /

+0.22 (+1.62%)

Arcturus Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Neptune Wellness completes FDA submission for registration of NC facility » 07:04
04/09/20
04/09
07:04
04/09/20
07:04
NEPT

Neptune Wellness

$1.27 /

+0.105 (+9.05%)

Neptune Wellness is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Just Energy no longer in 'active discussions' regarding specific transaction » 07:04
04/09/20
04/09
07:04
04/09/20
07:04
JE

Just Energy

$0.56 /

+0.022 (+4.13%)

Just Energy provided an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Just Energy suspends door-to-door selling, in-store retail partnerships » 07:03
04/09/20
04/09
07:03
04/09/20
07:03
JE

Just Energy

$0.56 /

+0.022 (+4.13%)

Just Energy Group…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Theravance Biopharma to advance TD-0903 into clinical development » 07:02
04/09/20
04/09
07:02
04/09/20
07:02
TBPH

Theravance Biopharma

$23.50 /

+0.92 (+4.07%)

Theravance Biopharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Athenex says on track to submit NDA for oral paclitaxel following FDA meeting » 07:01
04/09/20
04/09
07:01
04/09/20
07:01
ATNX

Athenex

$8.37 /

+0.25 (+3.08%)

Athenex announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Visteon reducing production, costs, withdrawing guidance, donating face shields » 07:01
04/09/20
04/09
07:01
04/09/20
07:01
VC

Visteon

$50.05 /

+3.39 (+7.27%)

Company reducing…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Raytheon Technologies resumed with a Buy at UBS » 07:00
04/09/20
04/09
07:00
04/09/20
07:00
RTX

Raytheon Technologies

$62.66 /

+5.03 (+8.73%)

UBS analyst Myles Walton…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
PayPal price target lowered to $132 from $139 at Nomura Instinet » 06:59
04/09/20
04/09
06:59
04/09/20
06:59
PYPL

PayPal

$104.93 /

+4.7 (+4.69%)

Nomura Instinet analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
MasterCard price target lowered to $334 from $368 at Nomura Instinet » 06:58
04/09/20
04/09
06:58
04/09/20
06:58
MA

MasterCard

$270.81 /

+12.62 (+4.89%)

Nomura Instinet analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Visa price target lowered to $214 from $233 at Nomura Instinet » 06:58
04/09/20
04/09
06:58
04/09/20
06:58
V

Visa

$174.91 /

+6.44 (+3.82%)

Nomura Instinet analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Sonova downgraded to Hold from Buy at Jefferies » 06:58
04/09/20
04/09
06:58
04/09/20
06:58
SONVY

Sonova

$0.00 /

+ (+0.00%)

, WILLF

Demant

$0.00 /

+ (+0.00%)

Jefferies analyst Kit Lee…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
At Home Group announces temporary furloughs, salary reductions of associates » 06:58
04/09/20
04/09
06:58
04/09/20
06:58
HOME

At Home Group

$1.95 /

+0.42 (+27.54%)

At Home Group announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Ladenburg ups Novavax target to $28 on 'potent' COVID vaccine candidate » 06:57
04/09/20
04/09
06:57
04/09/20
06:57
NVAX

Novavax

$17.17 /

+2.3 (+15.47%)

Ladenburg analyst Michael…

Ladenburg analyst Michael Higgins raised the firm's price target on Novavax to $28 from $24 and keeps a Buy rating on the shares after the company identified NVX-CoV2373 as the COVID-19 vaccine candidate to take into clinical development. The news follows "significant" and "potent" preclinical results, including the induction of neutralizing antibodies and high immunogenicity in established animal models, Higgins tells investors in a research note. Unlike prior pandemics, the analyst is confident there is a market for a COVID-19 vaccine. Higgins, however, continues to see NanoFlu as Novavax's most valuable asset, which he says produced "impressive" Phase 3 results as a seasonal flu vaccine on March 24.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.